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ABSTRACT
Objective: The Social Role Participation Questionnaire
(SRPQ) assesses the influence of health on
participation in 11 specific and one general
participation role across 4 participation dimensions:
‘importance’, ‘satisfaction with time’, ‘satisfaction with
performance’ and ‘physical difficulty’. This study aimed
to translate the SRPQ into Dutch, and assess the
clinimetric properties and aspects of its validity among
patients with ankylosing spondylitis (AS).
Methods: Translation was performed using the dual
panel approach. For each participation dimension,
internal consistency, test-retest reliability (n=31), and
construct validity were assessed in 246 patients with
AS.
Results: The translation required only minor
adaptations. Cronbach αs were α≥0.7. A strong
correlation was present between satisfaction with
‘time’ and ‘performance’(r=0.85). Test-retest
reliability was satisfactory (κ=0.79–0.95).
Correlations with participation domains of the Short-
Form Health Survey 36 (SF-36), the WHO Disease
Assessment Score II, and generic as well as disease-
specific health outcomes (Physical and Mental
component scale of the SF-36, Satisfaction With Life
Scale, Bath Ankylosing Spondylitis Disease Index
(BASDAI), Bath Ankylosing Spondylitis Functioning
Index (BASFI)) were at least moderate (r=−0.41 to
0.75) for all dimensions except for ‘role importance’
where correlations were weak (r≤40). Discriminative
ability across 5 self-reported health states was good
for all dimensions (p<0.01). The ‘general
participation’ role showed similar reliability and
validity for each dimension, as the average of the all
11 roles.
Conclusions: The Dutch version of the SRPQ is
available to help understand social role participation
of patients with AS. The dimension ‘role importance’
measures a distinct aspect of participation. The
general participation item was a good global
measure of participation.
INTRODUCTION
Participation in social roles is increasingly
recognised by healthcare professionals, as
well as by policymakers, to be an important
outcome of healthcare and healthcare
services.
Ankylosing spondylitis (AS) is a chronic
inﬂammatory rheumatic disease with a usual
Key messages
What is already known about this subject?
▸ The Social Role Participation Questionnaire
(SRPQ) is a promising instrument as it assesses
a broad range of roles, including one ‘general
participation role’, across various participation
dimensions. The English version of the SRPQ
has proven to be reliable and valid for use in
patients with ankylosing spondylitis (AS) in
Canada.
What does this study add?
▸ The Dutch translation of the SRPQ was found
relevant and comprehensible by patients with
AS, and showed acceptable internal consistency
and test-retest reliability.
▸ The dimensions ‘satisfaction with time spent’
and ‘satisfaction with performance’ correlated
strongly. ‘Satisfaction with performance’ had
better construct validity, suggesting redundancy
of the dimension ‘satisfaction with time’.
▸ The dimension ‘role importance’ provides differ-
ent information, but these are likely to be add-
itional information.
How might this impact on clinical practice?
▸ The ‘general participation’ item had adequate
reliability construct validity and can, therefore,
be considered as a more feasible approach to
measure social role participation.
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onset in the third decade of life, when persons are com-
mitted to various social roles that adults fulﬁl.1 While a
large amount of literature is available on restrictions on
worker participation, the number of studies and the
knowledge about restrictions in the full spectrum of
adult social roles for patients with AS is limited.2 3
Research is hampered by continuing discussions on the
exact deﬁnition of participation and challenges to opera-
tionalising the concept.4
With regard to the deﬁnition, the International
Classiﬁcation of Functioning, Disability and Health
(ICF) deﬁnes participation as ‘an involvement in a life
situation’, and classiﬁes the concept as the aspect of
functioning beyond impairments in body functions and
activities, which are typical and relevant in the larger
setting of someone’s life.4 5
When operationalising the concept, existing instruments
ﬁrst vary according to the participation roles they include.
In a review of instruments, relationships with family and
friends, role at home, social (including political and reli-
gious life) life and work/education were recognised as
unmistakable participation roles. On the other hand, dis-
cussion remains whether sexual life, hobbies or travel/
transport reﬂect social role participation.6 Second, instru-
ments differ with respect to which aspects or dimensions
of social roles they measure. While the majority of instru-
ments address restrictions or difﬁculty in performance of
social roles,4 other aspects/dimensions of social role par-
ticipation seem to be relevant with regard to health and/
or the experience of health. From a patient-centered per-
spective, the level of ‘satisfaction’ can be of interest as it
provides additional information on the personal appraisal
of role performance independent of the difﬁculty or level
of social participation.7 Moreover, ‘role importance’ seems
highly relevant, as it includes the value the individual
attaches to this role and can provide meaningful informa-
tion that can be used as an additional qualiﬁer for partici-
pation scores.4
The Social Role Participation Questionnaire (SRPQ) is
a promising instrument as it assesses a broad range of
roles, including one ‘general participation role’, across
various dimensions.8 9 The English version of the SRPQ
has proven to be reliable and valid for use in patients
with AS and osteoarthritis in Canada.8 10 Since no vali-
dated Dutch patient-reported measure exists to assess
participation in Dutch patients with AS, the present
study aimed to translate the English version of the SRPQ
into Dutch, assess reliability, and further explore the
construct validity for Dutch patients with AS.
No major problems for translation and cultural adap-
tation were expected. With regard to internal consist-
ency and construct validity, it was hypothesised that the
‘importance’ dimension of the SRPQ would provide dis-
similar results because this dimension conceptually
differs from other dimensions. Finally, we expected that
the ‘general participation’ item would have a similar
construct validity compared with average scores of all 11
included roles in the SRPQ.
MATERIALS AND METHODS
SRPQ, translation and cultural adaptation
The initial version of the SRPQ assesses the inﬂuence of
health on 11 speciﬁc social roles and 1 ‘general partici-
pation’ item across 3 participation dimensions: ‘role
importance’, ‘satisfaction with time spent in roles’ and
‘satisfaction with the role performance’.9 As subsequent
validation showed a high correlation between the two
‘satisfaction’ dimensions and indicated that a dimension
on difﬁculty with participation was missing, a modiﬁca-
tion was proposed to exclude ‘satisfaction with time’ and
add ‘physical difﬁculty’.8 10 Given that this suggested
modiﬁcation for SRPQ was never validated, we decided
to include all four dimensions in the current study. All
roles of the SRPQ can be scored in each dimension on a
ﬁve-point Likert scale (1: not at all important/not at all
satisﬁed/unable to do to 5: extremely important/
extremely satisﬁed/no difﬁculty). For the roles employ-
ment, education, intimate relationships and relationship
with children/step-children/grandchildren, the patients
can indicate that this role is not applicable and conse-
quently, the ‘difﬁculty’ and ‘satisfaction dimensions’ will
not be completed (ﬁgure 1).
For each dimension, a summary score can be calcu-
lated for presenting the average of all roles. To deal with
non-applicable roles, for the dimension ‘physical difﬁ-
culty’ it is assumed that no restrictions are experienced
if the role is not applicable; however, for the satisfaction
dimensions the average scores are only calculated if par-
ticipants participate in at least 9 of the 11 roles.8
Translation of the SRPQ was performed following the
dual panel approach.11 First, four bilingual translators
(native Dutch speakers) and 2 native (English) speakers
worked together to produce a preliminary Dutch transla-
tion. Second, a healthy Dutch lay panel, consisting of
three women and three men varying in age (range 25–
64 years) and level of education, discussed the wording
and comprehensiveness of the translation under the
supervision of the project leader who was part of the
ﬁrst step. Finally, cognitive debrieﬁng interviews with the
adjusted version were conducted among ﬁve patients
with AS. The ﬁnal version was back-translated into
English and the developer’s approval was sought.
Clinimetric properties and validation
The COnsensus-based Standards for the selection of
health Measurement INstruments (COSMIN) guidelines
and checklist manual were used to ensure methodo-
logical quality of the current study.12 13
Participants
Patients were recruited as part of a multicentre cross-
sectional study, the Social Role Participation in
Ankylosing Spondylitis Study (SPASS). Patients from six
hospitals in the Netherlands who were at least 18 years
of age, registered with AS according to Dutch ‘diagnosis
related groups’ or similar patient lists, and in whom the
diagnosis, according to the modiﬁed New York criteria,
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was conﬁrmed by the treating rheumatologist were
invited to participate by a letter. Patients were excluded
if they indicated they had no access to the internet or
were not familiar with the Dutch language. A random
subsample of patients was invited to complete the SRPQ
again after 2 weeks to evaluate test-retest reliability. The
ethics committee of the academic hospital Maastricht
and Maastricht University approved the study, and
informed consent was obtained from all participating
patients.
Assessments
Patients completed an online survey. Questions on socio-
economic background comprised age, gender, highest
completed educational degree and work status. Social
participation was assessed using the SRPQ, and by social
role domains of the WHO Disease Assessment Score II
(WHODASII) and the Short Form Health Survey 36
(SF-36). The WHODASII contains 36 items across six
subdomains assessing difﬁculties in understanding and
communicating, getting around, self-care, getting along
with people, life activities, and participation in society.
The latter three subdomains are considered to represent
participation. Domain scores range from 0 to 100, lower
scores reﬂecting fewer limitations.14 The SF-36 contains
36 items assessing difﬁculties due to mental or physical
health across eight domains: social function, physical
function, bodily pain, role-physical, general health, vital-
ity, role-emotional and mental health. The domains
social functioning, role-physical and role-emotional rep-
resent participation roles. Domain scores range from 0
to 100 (higher scores reﬂecting less difﬁculties/health
problems). In addition, two summary scores, the
Physical Component Summary (PCS) and Mental
Component Summary (MCS) scores (range 0–100) can
be calculated to present overall health-related quality of
life (HR-QoL).15
To assess disease-speciﬁc aspects of health, patients
indicated their disease duration, current use of
tumour necrosis factor-α inhibitors, and completed
the Bath Ankylosing Spondylitis Disease Index (BASDAI)
and the Bath Ankylosing Spondylitis Functioning Index
(BASFI). The BASDAI is a composite score of six ques-
tions assessing different aspects of disease activity with
AS. Scores for each item and the total index range
from 0 to 10 (10 reﬂecting highest disease activity).16
The BASFI determines the level of normal daily func-
tioning of people with AS across 10 items. Scores for
each item and total index range from 0 to 10 (10
reﬂecting most impairments in functioning).17 Finally,
the Satisfaction With Life Scale (SWLS) was added to
assess the overall satisfaction with the respondent’s
life. The questionnaire has ﬁve items that can be rated
on a Likert scale (1 not at all agree to 7 totally agree).
Total scores range from 5 to 35, higher scores indicat-
ing more life satisfaction.18 19
Statistical analyses
Statistical analyses were performed using PASW Statistics
V.20 (SPSS, Chicago, Illinois, USA). Analyses are per-
formed for each dimension of the SRPQ by ﬁrst using
the averaged 11 speciﬁc role score and next the score
on the single ‘general participation’ item.
Internal consistency was assessed by Cronbach’s α coefﬁ-
cients (adequate: ≥0.70).20 Item deletion analyses were
performed to reveal any outstanding items inﬂuencing
the Cronbach’s α. Spearman correlations between
dimensions were computed (correlation weak: ≤0.40;
moderate: >0.41 but ≤0.75; strong: >0.75).21
Floor and ceiling effects were deﬁned as >15% of patients
scoring not at all important/not at all satisﬁed/unable
to do (ﬂoor effect) or >15% of patients scoring very
important/very satisﬁed/no difﬁculty (ceiling effect), in
the dimensions score or single item score.22
Figure 1 Graphical
representation of the content of
the Social Role Participation
Questionnaire (SRPQ), which
assesses several dimensions of
role participation across 11
specific roles and general role
participation item.
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Test-retest reliability was assessed assuming stable health
over the 2 weeks’ assessment interval, ﬁrst by weighted
κs with quadratic weights (agreement slight (≤0.2), fair
(>0.2 but <0.4), moderate (≥0.41 but <0.6), substantial
(≥0.6 but <0.8) and almost perfect (≥0.81)),23 and
second by the smallest detectable difference (SDD).
Construct validity with other participation measures was
tested by Spearman correlations with the participation
domains of the WHODASII6 and the SF-36. Construct
validity with other health outcomes was tested using
Spearman correlations with PCS and MCS of the SF-36,
BASDAI, BASFI and SWLS.
Finally, to assess whether the SRPQ is discriminative
between groups that differ in overall health (the ﬁve
health states of the SF-36 general health item (1=poor to
5=excellent health)), differences between provided
scores within each dimension were calculated by using
Kruskal-Wallis test.
RESULTS
Translation and cultural adaptation
The translator and lay panel identiﬁed issues concerning
the wording of the roles representing work and educa-
tion. The original English version asks about the type of
paid work or education that ‘you are able to have’ and
not ‘you are able to do’ as for all other roles. The panels
considered this difference as liable to misinterpretation.
Moreover, in the Dutch situation, ‘able to have’ would
be less applicable and ambiguous, as society focuses on
maintaining work and less on considering other types of
work. Hence, formulation was changed in accordance
with the questioning in the other roles. Results of the
cognitive debrieﬁng showed that the translated version
of the questionnaire was correctly understood, and no
roles or dimensions were missing or unimportant. The
average time to complete the SRPQ was 12±7 min. The
back-translated ﬁnal version was approved by the
developer.
Clinimetric properties of the SRPQ
Samples
Of the 740 patients invited, 296 (40%) agreed to partici-
pate of which 246 (83%) completed the questionnaire.
Of these patients, 31 participated in the test-retest reli-
ability substudy. The characteristics of the study popula-
tion are given in table 1. Most patients were male
(62%), average age 51±12 years and diagnosis duration
of 17±12 years. For roles that might not be applicable,
the table also presents the number and proportions of
persons for whom roles were applicable. This resulted in
n=235 (96%) patients who had participated in at least
nine roles (and therefore contribute to the satisfaction
dimension).
Internal consistency
Cronbach’s α was adequate for all dimensions but, as
hypothesised, this was lower for ‘role importance’
(α=0.74) compared with the ‘satisfaction with time’
(α=0.83), ‘satisfaction with performance’ (α=0.89) and
‘physical difﬁculty’ (α=0.86). Item deletion did not indi-
cate any outstanding items inﬂuencing Cronbach’s α.
The correlations between the dimension ‘role import-
ance’ and each other dimension were weak (‘satisfaction
with time’ (r=0.20), ‘satisfaction with performance’
(r=0.21) and ‘physical difﬁculty’ (r=0.10)). Strong corre-
lations were observed between both ‘satisfaction’ dimen-
sions (r=0.85), and moderate correlations between
‘physical difﬁculty’ and either ‘satisfaction with perform-
ance’ (r=0.69) or ‘satisfaction with time’ (r=0.52). The
correlations between the single general participation
item and the averages role scores were moderate for the
dimension ‘role importance’ (r=0.59), and strong for
the other dimensions (r≥0.80).
Floor and ceiling effects
In none of the dimensions were ﬂoor or ceiling effects
found. The general participation item showed a ceiling
effect in 43% of patients in the dimension ‘role import-
ance’ (participation very important).
Test-retest reliability
The weighted κ was substantial in the ‘role importance’
dimension (κ=0.79), and almost perfect for the
Table 1 Characteristics of 246 patients with ankylosing
spondylitis
n, Per cent or mean (SD)
[minimum–maximum]
Gender (males) 153 (62%)
Age (years) 51 (12) [24–79]
Diagnosis duration (years) 16.8 (11.8) [5–44]
BASDAI 4.4 (2.3) [0–10]
BASFI 4.2 (2.5) [0–10]
Current use of TNF-α
inhibitors (n, %)
123 (50%)
Higher professional education
or university
(n, %)
81 (33%)
SF-36 PCS 38.7 (10.1) [5.2–61.9]
SF-36 MCS 49.2 (12.8) [10.9–70.5]
SWLS 22.2 (7.2) [5–35]
SRPQ roles that are optional
Has a partner, intimate
relationship (n, %)
187 (79%)
Has (step/grand) children 184 (75%)
Has other family 239 (98%)
Employment (n, %) 140 (57%)
Work disabled (n, %) 59 (24%)
Following some form of
education (n, %)
40 (16%)
BASDAI, Bath Ankylosing Spondylitis Disease Index; BASFI, Bath
Ankylosing Spondylitis Functioning Index; MCS, Mental
Component Score; PCS, Physical Component Score; SF-36,
36-item Short Form Health Survey; SRPQ, Social Role
Participation Questionnaire; SWLS, Satisfaction With Life Scale;
TNF, tumour necrosis factor.
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dimensions ‘satisfaction with time’ (κ=0.84), ‘satisfaction
with performance’ (κ=0.85) and ‘physical difﬁculties’
(κ=0.95). The reliability of the general participation
item was lower, with a κ that was fair for ‘role import-
ance’ (κ=0.30) and substantial (κ≥0.7) for the other
dimensions. The SDDs for averaged scores and general
participation score [in square brackets] were 0.74 [1.60],
0.69 [1.23], 0.83 [1.35] and 0.38 [1.29] for the dimen-
sions ‘role importance’, ‘satisfaction time’, ‘perform-
ance’ and ‘physical difﬁculty’, respectively.
Construct validity
As expected, the dimension ‘role importance’ correlated
weakly with the six participation domains of WHODAS
or SF-36 (table 2). ‘Satisfaction’ with time or perform-
ance correlated moderately with three or ﬁve external
measures of participation, respectively. ‘Physical difﬁ-
culty’ correlated moderately with ﬁve participation mea-
sures. Correlations of the general participation item with
external measures were comparable to the correlations
based on the averages of speciﬁc roles. The weak
correlations for the satisfaction and difﬁculty dimensions
were always seen with the ‘emotional role’ of the SF-36.
The dimension ‘role importance’ correlated weakly
with all ﬁve measures representing aspects of HR-QoL
(table 3). ‘Satisfaction with time’ correlated moderately
with two, and weakly with three HR-QoL measures.
‘Satisfaction with role performance’ and ‘physical difﬁ-
culty’ correlated moderately with all available HR-QoL
measures, except for a weak correlation between the
dimension ‘physical difﬁculty’ and the SF-36 MCS.
Finally, the general participation item showed moderate
correlations for all dimensions with the exception of
‘role importance’, which showed a weak correlation.
Overall, the best correlations were seen between the ‘sat-
isfaction’ dimensions and SWLS, and between the ‘phys-
ical difﬁculty’ dimension and SF-36 physical role, BADAI
and BASFI.
Discriminative ability
Finally, all dimensions as well as the general participation
item were discriminative between the ﬁve health states of
Table 2 Spearman correlation coefficients of the SRPQ dimensions and other domains of questionnaire assessing
participation
SF-36 social
functioning
SF-36 role
emotional
SF-36 role
physical
WHODASII
getting along
with people
WHODASII
life activities
WHODASII
overall
participation
SRPQ dimension (average of all roles)
Role importance 0.063 0.003 0.255 −0.181 −0.009 −0.058
Satisfaction time* 0.586 0.378 0.335 −0.399 −0.435 −0.562
Satisfaction performance* 0.720 0.390 0.560 −0.461 −0.546 −0.646
Physical difficulty 0.735 0.384 0.713 −0.471 −0.714 −0.665
SRPQ general participation item
Role importance 0.075 0.018 0.164 −0.094 0.133 −0.040
Satisfaction time 0.603 0.377 0.392 −0.412 −0.444 −0.566
Satisfaction performance 0.582 0.323 0.464 −0.402 −0.453 −0.575
Physical difficulty 0.693 0.390 0.611 −0.461 −0.640 −0.625
*Average scores of the ‘satisfaction’ dimensions could only be calculated for 235 of the 246 patients.
SF-36, 36-item Short Form Health Survey; SRPQ, Social Role Participation Questionnaire; WHODAS, WHO Disease Assessment Score.
Table 3 Spearman correlation coefficients of the SRPQ and other instruments assessing generic or disease-specific
(aspects of) health in AS
SF-36 PCS SF-36 MCS SWLS BASDAI BASFI
SRPQ dimension (average all roles)
Role importance 0.146 0.004 0.166 −0.040 −0.260
Satisfaction time* 0.335 0.528 0.656 −0.339 −0.359
Satisfaction performance* 0.504 0.490 0.653 −0.483 −0.546
Physical difficulty 0.691 0.350 0.468 −0.636 −0.723
SRPQ general participation item
Role importance 0.108 −0.004 0.168 0.002 −0.157
Satisfaction time 0.383 0.503 0.649 −0.370 −0.380
Satisfaction performance 0.439 0.422 0.652 −0.415 −0.426
Physical difficulty 0.634 0.379 0.457 −0.583 −0.585
*Average scores of the ‘satisfaction’ dimensions could only be calculated for 235 of the 246 patients.
AS, ankylosing spondylitis; BASDAI, Bath Ankylosing Spondylitis Disease Index; BASFI, Bath Ankylosing Spondylitis Functioning Index;
MCS, Mental Component Score; PCS, Physical Component Score; SF-36, 36-item Short Form Health Survey; SRPQ, Social Role
Participation Questionnaire; SWLS, Satisfaction With Life Scale.
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the general health question in the SF-36 (table 4), except
for the dimension ‘role importance’ in the general par-
ticipation item.
DISCUSSION
This study translated and culturally adapted the SRPQ
into Dutch, and further tested several aspects of its valid-
ity among patients with AS. The translated questionnaire
was found to be relevant and comprehensible by Dutch
patients with AS; it showed overall good clinimetric
characteristics and conﬁrmed the hypothesis on con-
struct validity.
In rheumatology, translation followed by back transla-
tion and cognitive debrieﬁng among patients as the last
step is the most common approach to translate and cul-
turally validate questionnaires. Our study conﬁrms that
the dual panel approach provides greater efﬁcacy due to
more intense involvement of possible end users.11 24–28
By using the dual panel approach, we identiﬁed at an
early stage (before the cognitive debrieﬁng) the need to
change the wording for the roles education and work in
the dimension ‘satisfaction with performance’ as
patients found the initially proposed translation difﬁcult
to interpret, liable to make mistakes and less applicable
in Dutch society. The proposed adaptations were subse-
quently tested in the cognitive debrieﬁng round and
were not considered to be ambiguous anymore.
As hypothesised, the dimension ‘role importance’
showed lower internal consistency, weak correlations
with the other dimensions of the SRPQ, and weak cor-
relation with other instruments assessing either partici-
pation or an aspect of health. Clearly, the assessment of
‘role importance’ provided different information than
other dimensions and can, therefore, be useful in the
interpretation of the relevance of scores of the remain-
ing dimensions. Further, it was conﬁrmed that both
dimensions for ‘satisfaction’ correlated strongly. As ‘satis-
faction with performance’ had somewhat better
construct validity for all hypotheses tested (correlation
with other participation measures, correlation with
HR-QoL and discriminative ability across groups with dif-
ferent health states), ‘satisfaction with time’ seems less
informative and redundant. On the other hand, the
dimension ‘physical difﬁculty’, that was added later to
the SRPQ, was found to have good correlations with
external measures of participation and with HR-QoL,
and discriminated particularly well across different
health states. The dimension ‘satisfaction with perform-
ance’, as opposed to ‘physical difﬁculty’, was not found
redundant as it correlated better with MCS and SWLS.
In AS, only one other study reported on participation
in social roles. Davis et al10 previously reported on the
validity of the original SRPQ in Canada and included 44
patients with AS. It is to be noted that in this version the
dimension ‘physical difﬁculty’ was not tested. The
authors found comparable Cronbach’s α, acceptable
test-retest reliability and conﬁrmed redundancy for both
satisfaction scales. Regarding comparison with other
instruments measuring participation, it should be men-
tioned that Davis included different measures, and
reported also moderate correlations of the SRPQ satis-
faction scales with the Keele Assessment of Participation,
which measures participation in roles ‘as and when you
want it’,29 and the Late Life Disability Instrument evalu-
ating the frequency and limitations in performing life
tasks.30 This adds to the validity of the SRPQ as in our
study it needs to be recognised that the instruments to
assess construct validity participation (SF-36 role
domains and WHODASII participation dimensions)
addressed only the dimension physical restrictions of
participating, therefore somewhat limiting the validation
of the ‘satisfaction’ dimensions.
By analysing and presenting the results of the dimen-
sions of the SRPQ as averages of all 11 roles, information
on clinimetrics and validity of the speciﬁc roles could be
missed. Additional analyses showed that clinimetrics and
the validity of these items did not differ overall from
Table 4 Average SRPQ scores across SF-36 rated health states for 246 patients with AS
SF-36 current health state
Poor
N=20
8.1%
Fair
N=109
(44.3%)
Good
N=93
37.8%
Very good
N=22
8.9%
Excellent
N=2
0.8% p Value
SRPQ dimensions (average all roles)
Importance (1–5) 3.59 3.65 3.85 3.96 4.15 0.024
Satisfaction time* (1–5) 2.47 2.99 3.47 3.82 3.90 <0.001
Satisfaction performance* (1–5) 2.36 2.85 3.54 4.04 4.01 <0.001
Physical difficulty (1–5) 3.45 3.82 4.33 4.67 5.00 <0.001
SRPQ general participation item
Importance 4.25 4.18 4.25 4.64 5.00 0.062
Satisfaction time 2.45 2.97 3.55 4.18 4.00 <0.001
Satisfaction performance 2.15 2.59 3.41 4.14 3.50 <0.001
Physical difficulty 2.45 3.18 3.85 4.36 5.00 <0.001
*Average scores of the ‘satisfaction’ dimensions could only be calculated for 235 of the 246 patients. SRPQ dimension scores range from (1:
not at all important/not at all satisfied/unable to do to 5: extremely important/extremely satisfied/no difficulty).
AS, ankylosing spondylitis; SF-36, 36-item Short Form Health Survey; SRPQ, Social Role Participation Questionnaire.
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results based on average scores, and no clear pattern with
regard to a speciﬁc role could be seen (see online supple-
mentary ﬁle). As a ﬁrst step to increase the feasibility of
the SRPQ, the validity of the summary role ‘general par-
ticipation’ was explored, and this showed that this single
item had a high ﬂoor effect for role importance (very
important) and somewhat lower (yet with acceptable reli-
ability) similar correlations with external instruments,
and appropriate discriminative ability across self-reported
health states. Although ‘global’ constructs are informative
as secondary end points, there is also a risk to loose infor-
mation. Additional research, such as item response
theory or factor analyses, could help in reducing the
number of roles.
Some limitations need to be considered. First, the
sample of patients unexpectedly included more females
and the average age was higher than in most of the
cross-sectional samples of patients with AS.1 Although it
is known that AS is increasingly recognised in females,31
it cannot be excluded that some patients might in fact
have non-radiographic axial spondyloarthritis (nr-
axSpA) (which is also more frequent in females).
Second, when items in the SRPQ are not applicable
there are theoretical different approaches to account for
in the calculation of the dimension scores. In this study,
it was chosen to adhere to the instruction of the original
articles to allow for better comparison with the other
publications on the validity of the SRPQ. Third, when
evaluating test-retest reliability, erroneously no external
measure to evaluate stability of health was added.
Overall, it is considered that a 2-week period in a
chronic disease is considered an appropriate time inter-
val to avoid a change in health, on the one hand, and
avoid a recall bias on the other hand.20 More import-
antly, some aspects of the measurement properties have
not yet been addressed. A priority is to deﬁne thresholds
to enhance interpretability of the scores with regard to
clinical important differences and patient acceptable
participation state, and to study sensitivity to change.
Finally, although the ‘importance dimension’ is consid-
ered relevant, a feasible approach to include this dimen-
sion in a global interpretation of social role participation
is needed
The relevance of this study is clear. The availability of
a validated version of a Dutch version of the SRPQ will
help researchers to gain more insight on participation as
a health outcome, and the role of participation to dir-
ectly or indirectly predict long-term satisfaction with life
(happiness), vitality and healthy ageing, as well as
resource utilisation and even mortality. Although rele-
vant for patients, limitations in participation should not
be a reason to change the pharmacological treatment,
but should rather be a reason to consider non-
pharmacological interventions comprising of lifestyle
advise, education on coping strategies or the organisa-
tion of help from caretakers, friends or colleagues.
In summary, the Dutch SRPQ was understood well by
the current sample of patients with AS. The version
addressing the dimensions ‘role importance’, ‘satisfac-
tion with performance’ and ‘physical difﬁculty’ showed
acceptable reliability and validity. The general participa-
tion item of the SRPQ seems to be a good substitute for
the 11 other roles. It can, therefore, be considered to be
a more feasible way to measure social role participation.
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